Skip to main content
. Author manuscript; available in PMC: 2014 Jan 22.
Published in final edited form as: Int Perspect Sex Reprod Health. 2011 Mar;37(1):16–23. doi: 10.1363/3701611

Table 4.

Women’s contraceptive use status after discontinuation of baseline method among women experiencing the same side effect, by selected characteristics, Honduras, 2006–2007

Discontinuation with amenorrhea (N=66) Switched
n=22
%
Discontinued
N=44
%
  Side effects interfered with daily activities 59.1 43.2
  Side effects interfered with relationship with partner 27.3 20.5
  Self-medicated or took home remedies* 13.6 34.1
  Sought help from a clinic or health worker** 63.6 36.4
  Discussed side effects with 2 or more people* 95.5 79.6
  Discussed side effects with partner 68.2 50.0
  Discussed side effects with family member(s) 40.9 31.8
  Discussed side effects with friends 9.1 9.1
  Discussed stopping baseline method with partner before making decision to discontinue 90.9 77.3

Discontinuation with heavy bleeding (N=64) Switched n=36 % Discontinued N=28 %

  Side effects interfered with daily activities 75.0 75.0
  Side effects interfered with relationship with partner 72.2 71.4
  Self-medicated or took home remedies 19.4 21.4
  Sought help from a clinic or health worker 72.2 57.1
  Discussed side effects with 2 or more people** 100.0 85.7
  Discussed side effects with partner*** 80.6 46.4
  Discussed side effects with family member(s) 38.9 42.9
  Discussed side effects with friends 19.4 25.0
  Discussed stopping baseline method with partner before making decision to discontinue*** 97.2 67.9

Discontinuation with headaches (N=82) Switched n=36 % Discontinued N=46 %

  Side effects interfered with daily activities 66.7 71.7
  Side effects interfered with relationship with partner 41.7 47.8
  Self-medicated or took home remedies* 36.1 56.5
  Sought help from a clinic or health worker 58.3 45.7
  Discussed side effects with 2 or more people 94.4 89.1
  Discussed side effects with partner 69.4 63.0
  Discussed side effects with family member(s) 33.3 43.5
  Discussed side effects with friends 19.4 15.2
  Discussed stopping baseline method with partner before making decision to discontinue** 88.9 69.6
*

p<0.1;

**

p<0.05;

***

p<0.01